Advertisement
UK markets closed

  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     

  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     

  • AIM

    789.87
    +6.17 (+0.79%)
     

  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     

  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     

  • Bitcoin GBP

    48,491.36
    -1,731.75 (-3.45%)
     

  • CMC Crypto 200

    1,261.13
    -96.88 (-7.13%)
     

  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     

  • DOW

    39,512.84
    +125.08 (+0.32%)
     

  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     

  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     

  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     

  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     

  • DAX

    18,772.85
    +86.25 (+0.46%)
     

  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     
MONEY:

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

New Strong Sell Stocks for May 17th

Zacks Equity Research
·1-min read

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

Baidu, Inc. BIDU is an internet search services company. The Zacks Consensus Estimate for its current year earnings has been revised 11.5% downward over the last 60 days.

Emergent BioSolutions Inc. EBS is a life sciences company. The Zacks Consensus Estimate for its current year earnings has been revised 7.3% downward over the last 60 days.

Frontline Ltd. FRO is a shipping company engaged in the seaborne transportation of crude oil and oil products. The Zacks Consensus Estimate for its current year earnings has been 7.1% downward over the last 60 days.

ADVERTISEMENT

View the entire Zacks Rank #5 List.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Baidu, Inc. (BIDU) : Free Stock Analysis Report

Frontline PLC (FRO) : Free Stock Analysis Report

Emergent Biosolutions Inc. (EBS) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research